IDEAYA Biosciences Price/Book Ratio 2018-2024 | IDYA

IDEAYA Biosciences price/book ratio from 2018 to 2024. Price/book ratio can be defined as

IDEAYA Biosciences Price/Book Ratio 2018-2024 | IDYA

IDEAYA Biosciences price/book ratio from 2018 to 2024. Price/book ratio can be defined as
Related Stocks
Company NameMarket
Cap
Amgen (AMGN)$149.8B
Vertex Pharmaceuticals (VRTX)$120.3B
Bristol Myers Squibb (BMY)$115.2B
Gilead Sciences (GILD)$110.2B
CSL (CSLLY)$85.5B
Regeneron Pharmaceuticals (REGN)$83.7B
GSK (GSK)$69.8B
Argenex SE (ARGX)$34B
Alnylam Pharmaceuticals (ALNY)$30B
BioNTech SE (BNTX)$24.4B
Biogen (BIIB)$23B
Illumina (ILMN)$20.7B
BeiGene (BGNE)$18.3B
Moderna (MRNA)$15.2B
Incyte (INCY)$14.8B
Genmab (GMAB)$13.7B
Insmed (INSM)$11.9B
BioMarin Pharmaceutical (BMRN)$11.8B
Vaxcyte (PCVX)$10.8B
Bio-Techne Corp (TECH)$10.6B
Sarepta Therapeutics (SRPT)$10B
Exelixis (EXEL)$9.9B
Bio-Rad Laboratories (BIO.B)$9.4B
QIAGEN (QGEN)$9.4B
Exact Sciences (EXAS)$9.2B
Revolution Medicines (RVMD)$9.1B
Intra-Cellular Therapies (ITCI)$8.7B
Roivant Sciences (ROIV)$8.3B
Ascendis Pharma (ASND)$7.4B
Repligen (RGEN)$6.9B